| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.2B | $17.5B | $18.1B | $19.4B | $6.1B | $6.8B | $6.8B | $6.8B |
| Cost of Revenue | $9.7B | $10.5B | $11.5B | $11.4B | $4.0B | $4.4B | $4.3B | — |
| Gross Profit | — | — | — | — | — | — | — | $2.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $5.3B | $5.5B | $5.6B | $5.5B | $1.6B | $1.7B | $1.7B | $1.5B |
| Operating Income | $0.4B | $0.7B | $0.2B | $1.7B | $-0.3B | $1.1B | $1.4B | $1.4B |
| Net Income | $0.1B | $0.3B | $-0.0B | $0.9B | $0.3B | $0.3B | $0.3B | $0.5B |
| EPS (Basic) | $0.98 | $2.88 | $-0.15 | $6.41 | $2.23 | $1.72 | $1.68 | $2.83 |
| EPS (Diluted) | $0.98 | $2.85 | $-0.15 | $6.32 | $2.20 | $1.72 | $1.67 | $2.81 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.6B | $14.0B | $14.3B | $15.1B | $15.3B | $14.6B | $12.5B | $13.3B |
| Current Assets | $3.4B | $3.4B | $3.7B | $5.0B | $5.8B | $4.6B | $4.8B | $5.3B |
| Cash & Equivalents | $0.1B | $0.2B | $0.2B | $1.6B | $2.3B | $0.7B | $0.9B | $1.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.1B | $2.6B | $3.1B | $3.3B | $3.0B | $2.8B | $2.7B | $2.7B |
| Stockholders' Equity | $3.8B | $3.9B | $3.8B | $4.7B | $5.2B | $5.5B | $5.5B | $5.4B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $1.2B | $0.3B | $2.3B | $1.3B | $1.7B | $2.1B | $1.7B |
| Investing Cash Flow | $-0.5B | $-0.6B | $-0.8B | $-0.6B | $-0.1B | $-0.8B | $-0.6B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $-0.6B | $-0.9B | $-2.4B | $0.3B | $-1.0B | $-1.9B | $-0.8B |